年度回顾2023年 - 回到未来
Luca Cristiani1, Flávia Fonseca Fernandes2
1Pneumology and Cystic Fibrosis Unit, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
概括
在2023年的现实研究中,elexacaftor-tezacaftor-ivacaftor (ETI) 在囊性纤维化 (CF) 患者中显示了持续的益处. 然而,神经心理方面的副作用和公平的接入需要持续关注全面的CF护理.
科学领域:
- 医学研究 医学研究
- 肺部病理学 肺部病理学
- 遗传学 遗传学 是一个
背景情况:
- 囊性纤维化 (CF) 是一种影响多个器官的遗传性疾病.
- CFTR调节器代表了CF治疗的重大进步.
- 需要持续评估elexacaftor-tezacaftor-ivacaftor (ETI) 的影响.
研究的目的:
- 审查2023年关于ETI在囊性纤维化护理中的影响的文献.
- 评估与ETI治疗相关的现实世界的好处和挑战.
- 识别CF管理中的新兴趋势和未满足的需求.
主要方法:
- 对2023年发表的文章进行系统的文献综述.
- 对ETI有效性和安全性的现实数据的分析.
- 对补充性和新型CF治疗方法的研究综合.
主要成果:
- 现实世界的证据证实了ETI在不同年龄组的持续临床益处.
- 与ETI治疗相关的神经心理副作用仍然是一个显著的挑战.
- 研究正在扩展到远程医疗应用和CF的创新治疗策略.
结论:
- ETI对囊性纤维化治疗产生了显著的积极影响.
- 解决持续的副作用和确保公平的获取对于优化CF结果至关重要.
- 对新型疗法和护理模式的持续研究对于全面的CF管理至关重要.
关键词:
囊性纤维化 囊性纤维化相关概念视频
Super-resolution Fluorescence Microscopy
7.0K
Super-resolution fluorescence microscopy (SRFM) provides a better resolution than conventional fluorescence microscopy by reducing the point spread function (PSF). PSF is the light intensity distribution from a point that causes it to appear blurred. Due to PSF, each fluorescing point appears bigger than its actual size, and it is the PSF interference of nearby fluorophores that causes the blurred image. Various approaches to achieving higher resolution through SRFM have recently been...
7.0K
CRISPR
50.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.9K
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K


